Excoiting, page-9

A positive responses from reviews of MAA at the TGA - so positive that the process is still going on some 10 months past the expected decision time and not expected for another 4 months.

SUDA has been dealing with Artimist since 2008 and here its 2019 - a new drug could have been brought to the market in that time but lack of skill, money, leadership has it where it is.

I dont think that getting the MAA now is going to have as big as an affect on the sp as people think - so much promise - so much not delivered